TR200301614A2 - Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem - Google Patents

Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem

Info

Publication number
TR200301614A2
TR200301614A2 TR2003/01614A TR200301614A TR200301614A2 TR 200301614 A2 TR200301614 A2 TR 200301614A2 TR 2003/01614 A TR2003/01614 A TR 2003/01614A TR 200301614 A TR200301614 A TR 200301614A TR 200301614 A2 TR200301614 A2 TR 200301614A2
Authority
TR
Turkey
Prior art keywords
preparation
new method
tablet formulation
atorvastatin calcium
calcium tablet
Prior art date
Application number
TR2003/01614A
Other languages
English (en)
Inventor
Seyed Farshi Farhad
Original Assignee
Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2003/01614A priority Critical patent/TR200301614A2/tr
Priority to PCT/TR2004/000042 priority patent/WO2005030183A2/en
Publication of TR200301614A2 publication Critical patent/TR200301614A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; Atorvastatin kalsiyum filmtablet hazırlanmasında formülasyonda kullanılan yardımcı maddelerin olumsuz etkilerini ortadan kaldırmak amacıyla geliştirilmiştir.
TR2003/01614A 2003-09-26 2003-09-26 Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem TR200301614A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2003/01614A TR200301614A2 (tr) 2003-09-26 2003-09-26 Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem
PCT/TR2004/000042 WO2005030183A2 (en) 2003-09-26 2004-09-24 A method for the preparation of atorvastatin calcium tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2003/01614A TR200301614A2 (tr) 2003-09-26 2003-09-26 Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem

Publications (1)

Publication Number Publication Date
TR200301614A2 true TR200301614A2 (tr) 2005-10-21

Family

ID=34388831

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01614A TR200301614A2 (tr) 2003-09-26 2003-09-26 Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem

Country Status (2)

Country Link
TR (1) TR200301614A2 (tr)
WO (1) WO2005030183A2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2070520A1 (en) * 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
KR101950907B1 (ko) * 2016-02-05 2019-02-21 한국유나이티드제약 주식회사 지용성 약물 및 방유성 기제가 코팅된 고형제제를 포함하는 경구용 복합제제
CN106420645A (zh) * 2016-11-24 2017-02-22 浙江新东港药业股份有限公司 一种含阿托伐他汀钙片及制备方法
CN108421045B (zh) * 2018-04-02 2021-09-24 北京海晶生物医药科技有限公司 一种阿托伐他汀钙组合物、制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254219B2 (ja) * 1993-01-19 2002-02-04 ワーナー−ランバート・コンパニー 安定な経口用のｃｉ−９８１製剤およびその製法
JP3397385B2 (ja) * 1993-09-20 2003-04-14 第一製薬株式会社 崩壊遅延防止錠剤
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
SI20848A (sl) * 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Farmacevtska formulacija, ki vsebuje atorvastatin kalcij

Also Published As

Publication number Publication date
WO2005030183A3 (en) 2005-09-09
WO2005030183A2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
UA115131C2 (uk) Сполуки боронатного ефіру і його фармацевтичні рецептури
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
HN2003000054A (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas.
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
TNSN07020A1 (en) Her2 antibody composition
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
UY28342A1 (es) Nuevos compuestos
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CL2004000647A1 (es) Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am
NO20071604L (no) Loxapinanaloger og fremgangsmater for anvendelse derav.
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
UY31403A1 (es) "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos".
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
HRP20041013B1 (hr) Formulacija visoke doze ibandronata
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
SE0302546D0 (sv) New compounds
TR200301614A2 (tr) Atorvastatin kalsiyum tablet formülasyonunun hazırlanması için yeni yöntem
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
DE602004022515D1 (de) Fenofibrate tablett und verfahren zur herstellung
EA201100575A1 (ru) Композиция дигидрата 3-(2,2,2-триметилгидразиниум)пропионата для наружного местного применения